ArticleMolecular diversity2026
Adaptive AI framework for pharmacokinetics using GATs, transformers, and AutoML.
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate prediction of pharmacokinetic parameters is critical in drug discovery, yet traditional experimental approaches are time-intensive and costly. This study presents a real-time artificial intelligence framework that integrates graph attention networks, Transformer models, and automated machine learning to predict pharmacokinetic parameters, including those related to absorption, distribution, metabolism, and excretion. Unlike static models, our dynamic approach periodically incorporates newly available data, stratified by administration routes such as intravenous and oral, and recalibrates model parameters without full retraining. This flexibility enables the system to integrate new compounds from single-point measurements while maintaining high predictive accuracy over time. The optimized models achieved a mean coefficient of determination of 0.93 and a mean absolute error of 0.059, demonstrating improved performance compared to conventional batch learning techniques. Despite challenges such as computational costs and model interpretability, the proposed framework shows significant promise in enhancing scalability, responsiveness, and prediction accuracy, highlighting its potential to accelerate data-driven decision-making in drug development.
Indexed as
Identifiers
41160339What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.